Observational Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Observational Clinical Trials in Brazil

Observational Clinical Trials in Brazil – Clinical Trial Landscape

Observational clinical trials are a cornerstone of medical research, providing crucial insights into real-world patient experiences, treatment outcomes, and disease patterns. In Brazil, a country renowned for its vast and diverse population, observational trials play a significant role in advancing medical knowledge and improving healthcare practices.

This blog aims to explore the realm of observational clinical trials in Brazil, shedding light on their importance, process, benefits, and contributions to medical research for diverse populations.

Understanding Observational Clinical Trials

Observational clinical trials are research studies that observe participants in their natural settings, without intervention or manipulation. The primary objective is to gather data on health outcomes, treatment effectiveness, disease progression, and potential risk factors. These trials generate real-world evidence and expand our understanding of diseases, therapies, and healthcare interventions.

Significance of Observational Clinical Trials in Brazil

Brazil’s vast population, diverse ethnicities, and varied healthcare landscape make it an ideal setting for conducting observational clinical trials. These trials provide a unique opportunity to explore the impact of medical interventions within the Brazilian context and address the specific healthcare needs of its population.

Findings from these trials contribute to evidence-based healthcare decision-making, enabling healthcare professionals to deliver personalized and effective treatments.

Advantages of Observational Clinical Trials

  1. Real-world applicability: Observational trials provide insights into the effectiveness and safety of medical interventions in real-life settings, reflecting the everyday experiences of patients in Brazil.
  2. Diverse participant pool: Brazil’s rich ethnic and cultural diversity allows for a broader representation of patients in observational trials. This diversity enhances the generalizability of study findings and ensures that interventions are applicable to a wide range of populations.
  3. Long-term perspectives: Observational trials often track participants over extended periods, enabling researchers to assess long-term outcomes, treatment durability, and the impact of interventions over time.
  4. Cost-effectiveness: Observational trials can be more cost-effective and efficient than randomized controlled trials, making them an attractive option for studying larger populations and generating real-world evidence within limited resources.

Observational Clinical Trials in Brazil

Observational Clinical Trials in Brazil

Observational Clinical Trials in Brazil

Key Challenges in Conducting Observational Trials in Brazil

Despite their advantages, observational clinical trials in Brazil face several challenges that require careful consideration:

  1. Data quality and reliability: Ensuring accurate and comprehensive data collection is essential. Robust data management systems, standardized protocols, and rigorous quality control measures are crucial to maintain data integrity.
  2. Ethical considerations: Protecting participants’ rights, privacy, and confidentiality is of utmost importance. Researchers must adhere to ethical guidelines, obtain informed consent, and prioritize participant safety throughout the trial.
  3. Bias and confounding factors: Observational trials are susceptible to bias and confounding variables that can influence results. Researchers must employ rigorous statistical methods and study design techniques to account for these factors and minimize their impact.
  4. Regulatory compliance: Compliance with local regulatory bodies, such as the Brazilian Health Regulatory Agency (ANVISA), is necessary to ensure the study’s integrity and validity. Researchers must navigate through the necessary approvals and adhere to guidelines to conduct trials in an ethical and lawful manner.

Recent Advancements and Success Stories in Brazil

Brazil has made significant contributions to observational clinical trials, advancing medical knowledge and improving healthcare practices. Recent studies have covered a wide range of areas, including infectious diseases, chronic conditions, mental health, and public health interventions.

Notable success stories include trials evaluating the effectiveness of preventive measures in reducing disease transmission, assessing the impact of community-based interventions on disease management, and studying the real-world effectiveness of innovative therapies.

Collaboration and Future Prospects

Collaboration among researchers, healthcare institutions, government bodies, and international organizations is crucial for the continued success of observational clinical trials in Brazil.

By pooling resources, sharing expertise, and fostering collaborations, researchers can strengthen the observational trial landscape in Brazil. Increased funding and support will further enhance research infrastructure, promote data sharing, and encourage participation from diverse patient populations.

Future prospects for observational clinical trials in Brazil include embracing technological advancements to enhance data collection and analysis. The integration of digital health tools, such as electronic health records, wearable devices, and mobile applications, can facilitate real-time data capture and remote monitoring. This integration enables researchers to gather more comprehensive and timely information, leading to more accurate analyses and insights.

Additionally, fostering partnerships and knowledge exchange within Latin America can promote regional collaboration in observational clinical trials. Sharing experiences, resources, and best practices with neighboring countries can lead to a more comprehensive understanding of healthcare challenges in the region and foster the development of tailored interventions and policies.

Furthermore, leveraging big data analytics, artificial intelligence, and machine learning can provide researchers with powerful tools to analyze vast amounts of data collected during observational trials. These technologies can uncover patterns, identify potential risk factors, and support predictive modeling, leading to more personalized and targeted healthcare interventions.


Observational clinical trials in Brazil are vital for advancing medical research and improving healthcare outcomes for its diverse population. By studying patients in real-world settings, these trials generate valuable evidence that informs clinical practice, healthcare policies, and public health strategies.

Through collaboration, adherence to ethical guidelines, and the integration of innovative technologies, Brazil can continue to make significant contributions to medical knowledge and enhance patient care not only within the country but also in the broader Latin American region.

Observational Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Observational Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Observational Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Observational Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Observational Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Observational Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Observational Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Observational Clinical Trials in Brazil

The Cohortias Team

Observational Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Observational Clinical Trials in Brazil

Network & Partnerships